Our Activities

Our commitment towards research and development

orange

We at Ferrer like to do things in the best possible way.

 

To this end, we focus on what really sets us apart and centre our efforts and our energy on offering solutions that respond to the actual needs of people.

Being an inherent part of the pharmaceutical sector’s activities, Ferrer has always been committed towards seeking and developing new therapeutic alternatives aimed at responding to needs that are not covered or improving existing treatments, which in turn generates value for the patients, the healthcare systems and society as a whole.

Estrategia I+D

R&D Strategy

Ferrer’s R&D activities are centred around securing a portfolio of projects whose therapeutic value is differentiated, one and that is balanced in terms of risk and degree of innovation, incremental and disruptive. 

More 

orange
left
Partnering

Partnering

We at Ferrer aim to establish long-term relationships with biopharmaceutical and biotechnology companies that are active in the therapeutic areas we consider strategic. 

More 

left
Ferrer Open

Ferrer advanced biotherapeutics

This division is based on an open collaboration model, and it is centred around the search for and incorporation of disruptive projects of high added value, and therefore also of high technical risk. These are projects that are mainly born from academia or from start-ups that have carried out the entire non-regulated initial discovery of the product and who normally have a pre-clinical concept test. These are early collaboration projects that grant access to multi-disciplinary groups that have profound knowledge of the biology of illnesses, the potential targets capable of modifying the evolution of the pathologies and biological and clinical parameters that reflect said evolution.

GO TO FERRER OPEN

right
Info Science

Info Science

Info Science is the Ferrer Scientific Communication and Information Department corporate web site, and it allows users to carry out scientific or medical searches about our prescription products and to receive objective replies based on existing scientific evidence.

GO TO INFO SCIENCE

normal
left